State of the Art and New Trends from the 2022 Gism Annual Meeting

Int J Mol Sci. 2023 May 17;24(10):8902. doi: 10.3390/ijms24108902.

Abstract

The 2022 Italian Mesenchymal Stem Cell Group (Gruppo Italiano Staminali Mesenchimali, GISM) Annual Meeting took place on 20-21 October 2022 in Turin (Italy), with the support of the University of Turin and the City of Health and Science of Turin. The novelty of this year's meeting was its articulation, reflecting the new structure of GISM based on six sections: (1) Bringing advanced therapies to the clinic: trends and strategies, (2) GISM Next Generation, (3) New technologies for 3D culture systems, (4) Therapeutic applications of MSC-EVs in veterinary and human medicine, (5) Advancing MSC therapies in veterinary medicine: present challenges and future perspectives, (6) MSCs: a double-edged sword: friend or foe in oncology. National and international speakers presented their scientific works with the aim of promoting an interactive discussion and training for all attendees. The atmosphere was interactive, where ideas and questions between younger researchers and senior mentors were shared in all moments of the congress.

Keywords: Italian Mesenchymal Stem Cell Group (GISM); annual meeting; conference report; mesenchymal stem cells.

Publication types

  • Congress

MeSH terms

  • Humans
  • Italy
  • Medical Oncology*
  • Mesenchymal Stem Cells*

Grants and funding

This research received no external funding.